News & Events

TranSenda International, LLC, today announced the deployment of a clinical trial software

solution for Harvard Clinical Research Institute (HCRI) that expands the products and

services already under contract between the two parties. HCRI was seeking to continue the

process of simplifying its existing systems to manage and monitor various spreadsheets,

information and documents related to their clinical trials. To accomplish this, HCRI has

migrated from initially using TranSenda’s Clinical Trial Manager product to Office-Smart

Clinical Trial Manager™ and Office-Smart Clinical Payment Manager™. This subsequent

deployment also included the purchase of ClinBUS Connector™ along with professional

services to consolidate existing data sets into a single repository for clinical trial

management and related operational data.

By adding Office-Smart solutions to its organization, HCRI can now take advantage of

advanced capabilities that allow integration between Clinical Trial Manager and the

Microsoft® Office System. Office-Smart solutions also use TranSenda’s innovative ClinBUS®

data interchange technology to make data available through Microsoft SharePoint Server.

Among other advantages, ClinBUS enables the use of SharePoint data grids to connect

Microsoft Excel spreadsheets and databases, including Microsoft Access, to Office-Smart

solutions for data import or integration. With this new level of connectivity, HCRI can now

use previously hard-to-get-to data for the creation of SharePoint websites and dashboards—

and to make better use of their existing Microsoft Office tools, including Excel, Access,

Outlook and Word.

In addition to consolidating Microsoft Excel spreadsheet data, HCRI will also be integrating

Office-Smart Clinical Trial Manager with a number of Clinical Trial Data Management

Systems, including industry-leading Electronic Data Capture (EDC) system(s) as well as

their web-based learning management system. “Creating a single repository within Office-

Smart Clinical Trial Manager will significantly help with the managing of what are now three

independent processes supported by multiple systems,” said Robert Leonard, Chief

Information Officer at HCRI. “We also look forward to the fundamental improvements

TranSenda’s Office-Smart solutions can help bring to our clinical operations. Connecting our

Microsoft Office tools to work in conjunction with our study software represents an

important step toward simplifying our environment. Given the success we have had with

TranSenda so far, we are confident that we are on the right path to a more advanced and

efficient way to assist our sponsors and researchers managing clinical trials.”

TranSenda is committed to transforming the clinical trial software environment by delivering

solutions that address the underserved need to improve the "business-process" side of

clinical trial operations. With innovative Office-Smart clinical trial solutions, study

professionals can take full advantage of the Microsoft Office System to create a more

efficient workplace that unifies study software with the practical usefulness of Office

productivity tools. TranSenda International, LLC is a Microsoft Gold Certified Partner

headquartered in Bellevue, Washington, USA. For more information, visit

HCRI is an academic research organization, established by the Harvard Medical School, Beth

Israel Deaconess Medical Center and Partners HealthCare. The Institute provides an efficient

integration of industry and academic resources for clinical research and development. It

collaborates with associated academic researchers to offer expertise in a broad range of

therapeutic areas including interventional cardiology in which it is a recognized leader.

HCRI provides industry as well as academic researchers with a center for data collection,

management and analysis that is fully compliant with regulatory standards. HCRI is a

respected academic research organization (ARO) that also offers sponsors expert trial

design, safety management and independent centralized clinical endpoint event

adjudication.